Author

T. Horii

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Hoshino· 1 shared A. Ohsaka· 1 shared D. Motooka· 1 shared H. Kitamura· 1 shared I. Hatada· 1 shared K. Tsuchiya· 1 shared M. C. Alcantara· 1 shared M. Yuri· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Hoshino

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Fibroblast Nrf2 inhibits profibrotic transcription with Ddx54 and mitigates pathological fibrosis in the mouse heart and kidney

A. Hoshino, T. Nishiji, N. Ikemura, M. C. Alcantara, Y. Higuchi, Y. Uchio, Y. Kirita, S. Taminishi, Y. Ozaki, D. Motooka, R. Kobayashi, T. Horii, I. Hatada, S. Matoba

This study identifies the Keap1-Nrf2 pathway as a regulator of TGF-β-mediated CTGF expression in fibroblasts, showing that Nrf2 with Ddx54 suppresses profibrotic genes and reduces fibrosis in mouse heart and kidney.

bioRxiv · Nov 9, 2023 · PreprintCell Biology

Body Maps of Sound Pitch and its individual differences in Alexithymia and Depression

T. Daikoku, T. Horii, S. Yamawaki

This study explores how sound pitch perception relates to body sensations in individuals with depression and alexithymia, finding diffuse sensations and heightened anxiety.

bioRxiv · Jul 12, 2023 · PreprintPhysiology

A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib

Y. Tabe, H. Kitamura, K. Tsuchiya, M. Yuri, T. Ai, S. Misawa, T. Horii, A. Ohsaka, S. Kimura

This paper develops a new in-house RQ-PCR method for detecting BCR-ABL1 transcripts in CML patients, showing higher sensitivity than commercial methods for monitoring minimal residual disease.

bioRxiv · Oct 29, 2018Cancer Biology